Details for New Drug Application (NDA): 213932
✉ Email this page to a colleague
NDA 213932 describes CARIPRAZINE HYDROCHLORIDE, which is a drug marketed by Sun Pharm and Zydus and is included in two NDAs. Additional details are available on the CARIPRAZINE HYDROCHLORIDE profile page.
The generic ingredient in CARIPRAZINE HYDROCHLORIDE is cariprazine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cariprazine hydrochloride profile page.
The generic ingredient in CARIPRAZINE HYDROCHLORIDE is cariprazine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cariprazine hydrochloride profile page.
Summary for 213932
| Tradename: | CARIPRAZINE HYDROCHLORIDE |
| Applicant: | Sun Pharm |
| Ingredient: | cariprazine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 1.5MG BASE | ||||
| Approval Date: | Sep 30, 2022 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 3MG BASE | ||||
| Approval Date: | Sep 30, 2022 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 4.5MG BASE | ||||
| Approval Date: | Sep 30, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
